Early Psa Decline As A Predictor Of Progression In Patients With Metastatic Castration-Naive Prostate Cancer (Mcnpc) Treated With Abiraterone Acetate And Prednisone (Aa/P).

Pedro C. Barata,Iris Yeong Fung Sheng,Jaleh Fallah,Ruby Gupta,Hong Li,Kimberly D. Allman,Allison Martin,Moshe Chaim Ornstein,Timothy D. Gilligan,Brian I. Rini,Jorge A. Garcia

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 0|浏览7

暂无评分

摘要

e17542Background: Treatment intensification with androgen deprivation therapy (ADT) plus AA/P is a standard of care in patients with metastatic castration naive prostate cancer (mCNPC). Despite ini...

查看译文

关键词

prostate cancer,early psa decline,prednisone

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要